The Missing Mid-Year Review

Private equity firms are rigorous about two moments in the portfolio lifecycle: the initial diligence before acquisition, and the annual review. Everything in between gets managed through quarterly board meetings, ad-hoc calls, and the operating partner's judgment.

This leaves a significant gap in the middle of the year. By May, the 100-day plans from recent acquisitions should be well underway. Annual budgets are being tested against reality. Early signals about which portcos are tracking and which are drifting are becoming visible — if anyone is looking.

The mid-year health check is the structured review most funds skip. And skipping it means losing three to four months of potential course correction.

What a Portfolio Health Check Reveals

A structured mid-year review across the portfolio answers questions that quarterly reporting by individual portco does not:

• Which value creation plans are on track? Not just financially, but operationally. Are the initiatives that drive the thesis actually being executed?
• Where are the hidden risks? A portco can hit its revenue target while losing key talent, burning cash faster than planned, or neglecting customer retention. These risks do not always surface in financial summaries.
• Which portcos need more attention? Operating partner time is finite. The mid-year check helps allocate it based on data, not just who is loudest.
• Are there cross-portfolio patterns? If three portcos are all experiencing the same headwind — rising input costs, difficulty hiring, customer churn — that is a portfolio-level issue, not three individual ones.

Why Most Funds Skip It

The answer is almost always the same: they do not have the data infrastructure to make it practical. A structured portfolio health check requires consolidated, current data from every portco — financials, KPIs, headcount, pipeline, and operational metrics. If that data lives in disconnected systems and takes weeks to assemble, the health check becomes a project rather than a process.

It is much easier to default to the quarterly board meeting cadence and hope that the operating partners are catching issues in real time. Sometimes they are. Often they are not.

Making It Practical

The mid-year health check does not have to be a massive undertaking. When portfolio data is continuously consolidated, the review becomes a half-day exercise rather than a multi-week project:

Step 1: Generate a portfolio-wide dashboard showing actual vs. plan for the key financial and operational metrics across all portcos. With continuous data, this is a click, not a request.

Step 2: Flag the portcos where any key metric deviates from plan by more than 10%. These are the companies that need deeper review.

Step 3: For flagged companies, drill into the underlying drivers. Is the variance temporary or structural? Is management aware and acting, or unaware?

Step 4: Reallocate operating partner attention based on what the data shows, not what the last board meeting suggested.

The entire process takes a morning if the data is ready. It takes a month if it is not.

The Value of Early Course Correction

Catching a portco that is drifting from plan in May gives you seven months to correct course before the annual review. Catching it in December gives you a difficult conversation and a write-down. The math on early detection is compelling: every month of early intervention compounds into material value at exit.

Cofi makes the mid-year health check practical by keeping portfolio data continuously consolidated and audit-ready. No assembly required. Just open the dashboard and start the review.

Do not wait until December to find out what May could have told you. See portfolio health in real time at cofi.ai.